Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Tesla
TSLA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 16.790
- -0.220-1.29%
Close Jan 17 16:00 ET
- 16.900
- +0.110+0.66%
Pre 07:17 ET
454.80MMarket Cap-7.21P/E (TTM)
17.510High16.690Low225.18KVolume17.320Open17.010Pre Close3.81MTurnover0.91%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.74P/B416.41MFloat Cap14.30052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM4.82%Amplitude4.110Historical Low16.922Avg Price1Lot Size
Arcturus Therapeutics News
Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Piper Sandler Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $140
Arcturus Therapeutics (ARCT) Initiated With a Buy at Piper Sandler
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $74
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.
Arcturus Therapeutics Analyst Ratings
CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $74
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments
Buy Rating Justified by Arcturus Therapeutics' Market Potential and Strong Vaccine Efficacy
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.
Arcturus Therapeutics Analyst Ratings
Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.